IBT
EXC icon

International Biotechnology Trust’s Exelon EXC Stock Holding History

International Biotechnology Trust’s Portfolio EXC Stock Details EXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-766,241
Closed -$9.98M – 76
2021
Q4 		$9.98M Buy
+766,241
New +$28.9M 2.22% 18

Other funds holding EXC

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

International Biotechnology Trust's EXC Position: Q1 2022 in Review

International Biotechnology Trust sold out of Exelon (EXC) in Q1 2022, closing a stake of 766,241 shares — an estimated $9.98M sold.

International Biotechnology Trust first reported a position in EXC in Q4 2021 and held it in 1 quarter. The position peaked at $9.98M in Q4 2021. 1,025 funds tracked by Wall St. Rank hold EXC as of Q1 2022.

  • International Biotechnology Trust reported no remaining Exelon position as of Q1 2022 after selling out during the quarter.
  • International Biotechnology Trust sold 766,241 Exelon shares in Q1 2022, an estimated $9.98M.
  • International Biotechnology Trust first reported a position in Exelon in Q4 2021 and held it in 1 quarter.
  • International Biotechnology Trust's Exelon position peaked at $9.98M in Q4 2021.
  • 1,025 funds tracked by Wall St. Rank held Exelon as of Q1 2022.

Based on International Biotechnology Trust's 13F filing for Q1 2022, filed 20 May 2022.